CEA Valduc - Academic Profile | RDL Research Database

Publications

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Thierry Conroy , Françoise Desseigne , Marc Ychou +17 more

International audience

2011 New England Journal of Medicine 7440 citations

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

Axel Grothey , Eric Van Cutsem , Alberto Sobrero +17 more

No treatment options are available for patients with metastatic colorectal cancer that progresses after all approved standard therapies, but many patients maintain a good perfor...

2012 The Lancet 2789 citations

An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumors

Marc Ychou , Thierry Conroy , Jean‐François Seitz +4 more

2003 Annals of Oncology 112 citations

Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinoma

Franck Bonnetain , Laëtitia Dahan , E. Maillard +7 more

2010 European Journal of Cancer 106 citations

Affiliated Researchers

S. Gourgou-Bourgade

CEA Valduc

A. Kramar

CEA Valduc

Institution Info

Type: facility
Country: FR
Publications: 4
Citations: 10,447

External Links

Identifiers

ROR: https://ror.org/03ze07515